Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2024 01:00 ET | Source: Sequana Medical NV

Press Release: Publication in Kidney Medicine Highlights Benefits of DSR 2.0 for Sequana Medical’s Direct Sodium Removal Heart Failure Program and Board Composition Update

Publication in Kidney Medicine Highlights Benefits of DSR 2.0 for Sequana Medical’s Direct Sodium Removal Heart Failure Program and Board Composition Update More efficient sodium and fluid removal,...
November 26, 2024 01:00 ET | Source: Sequana Medical NV

Press Release: Transparency Notification from Shareholders

Transparency Notification from Shareholders Ghent, Belgium – 26 November 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid...
November 20, 2024 01:00 ET | Source: Sequana Medical NV

Press Release: Sequana Medical announces Extraordinary General Meeting of Shareholders on 20 December 2024

Sequana Medical announces Extraordinary General Meeting of Shareholders on 20 December 2024 Ghent, Belgium – 20 November 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or...
November 18, 2024 01:00 ET | Source: Sequana Medical NV

Press Release: Sequana Medical Announces Strong 24-Month Results from POSEIDON Study at AASLD The Liver Meeting® in San Diego; US PMA alfapump approval expected before end of Q1 2025

Sequana Medical Announces Strong 24-Month Results from POSEIDON Study at AASLD The Liver Meeting® in San Diego; US PMA alfapump approval expected before end of Q1 2025 alfapump was very effective in...
November 14, 2024 12:00 ET | Source: Sequana Medical NV

Press Release: Sequana Medical Announces New Share Capital Amount and New Number of Shares

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 14 November 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a...
October 23, 2024 01:00 ET | Source: Sequana Medical NV

Press release: SEQUANA MEDICAL ANNOUNCES ADDITIONAL CONVERTIBLE FINANCING OF UP TO EUR 1.0 MILLION FROM EXISTING INVESTORS

SEQUANA MEDICAL ANNOUNCES ADDITIONAL CONVERTIBLE FINANCING OF UP TO EUR 1.0 MILLION FROM EXISTING INVESTORS Ghent, Belgium, 23 October 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the...
October 21, 2024 12:00 ET | Source: Sequana Medical NV

Persbericht: SEQUANA MEDICAL KONDIGT NIEUW BEDRAG VAN KAPITAAL EN NIEUW AANTAL AANDELEN AAN

PERSBERICHT GEREGLEMENTEERDE INFORMATIE21 oktober 2024, 06:00 pm CEST SEQUANA MEDICAL KONDIGT NIEUW BEDRAG VAN KAPITAAL EN NIEUW AANTAL AANDELEN AAN Gent, België, 21 oktober 2024 – Sequana...
October 21, 2024 12:00 ET | Source: Sequana Medical NV

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

PRESS RELEASEREGULATED INFORMATION21 October 2024, 06:00 p.m. CEST SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 21 October 2024 – Sequana Medical NV...
October 10, 2024 11:40 ET | Source: Sequana Medical NV

Persbericht: Transparantiekennisgeving van Aandeelhouders

Transparantiekennisgeving van Aandeelhouders Gent, België – 10 oktober 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (de "Vennootschap" of "Sequana Medical"), een pionier in de behandeling van...
October 10, 2024 11:40 ET | Source: Sequana Medical NV

Press release: Transparency Notification from Shareholders

Transparency Notification from Shareholders Ghent, Belgium – 10 October 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid...